男性BRCA突变携带者的下尿路症状与良性前列腺增生特征
横断面研究纳入87例男性BRCA携带者与30例非携带者,比较下尿路症状及良性前列腺增生特征。非携带者最大尿流率更高(16.9 mL/s vs 12 mL/s,P=0.01)。BRCA1携带者前列腺体积、PSA及PSA密度均高于BRCA2携带者。
要点
- 男性BRCA突变携带者最大尿流率显著低于非携带者。
- BRCA1携带者前列腺体积、PSA及PSA密度高于BRCA2携带者。
- 年龄是BRCA2患者PSA密度的唯一显著预测因子。
核心结论
- 男性BRCA突变携带者的最大尿流率显著低于健康男性。
- BRCA1患者平均前列腺体积和PSA高于BRCA2患者。
- 需要进一步研究以阐明下尿路症状或良性前列腺增生与BRCA携带者的关联。
研究设计与样本
- 横断面研究纳入年龄40-70岁的男性BRCA携带者与非携带者,收集临床资料并填写国际前列腺症状评分,进行PSA血检、直肠指检、尿流率及排尿后残余尿超声检查,BRCA携带者常规随访中接受前列腺磁共振成像。
主要发现
- 共纳入87例携带者和30例非携带者,两组中位年龄、平均体质指数及合并症相似。
- 非携带者组最大尿流率高于携带者组(16.9 mL/s vs 12 mL/s,P=0.01)。
- 所有BRCA携带者平均前列腺体积为38.8 cc(标准差19.7)。
- BRCA1患者前列腺体积大于BRCA2患者(41.8 cc vs 33.1 cc,P=0.047)。
- BRCA1患者PSA高于BRCA2患者(1.84 ng/mL vs 1.07 ng/mL,P=0.006),PSA密度也更高(0.044 vs 0.032,P=0.042)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以阐明下尿路症状或良性前列腺增生与BRCA携带者的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze lower urinary tract symptoms and benign prostate hyperplasia features among male BRCA1 and 2 carriers and an age-matched control group. METHODS: Male BRCA carriers and noncarriers aged 40-70 years were enrolled in our cross-sectional study. Relevant clinical data were collected, and patients filled the International Prostate Symptom Score. Patients also underwent prostate-specific antigen (PSA) blood testing, digital rectal examination, uroflowmetry, and post-void residual ultrasound examination. As part of their routine follow-up, BRCA carriers underwent prostate magnetic resonance imaging. RESULTS: Overall, 87 carriers and 30 noncarriers were enrolled. The median age, mean body mass index, and comorbidities in both groups were similar. Maximal flow (QMAX) was higher in the noncarrier group (16.9 mL/s vs 12 mL/s, P = .01). Mean prostate volume among all BRCA carriers was 38.8 cc (19.7), but BRCA1 patients had larger glands with higher mean PSA and PSA density than BRCA2 patients (41.8 cc vs 33.1 cc, P = .047, 1.84 ng/mL vs 1.07 ng/mL, P = .006, and .044 vs .032, P = .042, respectively). Multivariate analysis demonstrated age being the sole significant predictor of PSA density in BRCA2 patients. CONCLUSION: Male carrying BRCA mutations have significantly lower QMAX than healthy men. BRCA1 patients have on average larger prostate glands and higher PSA than BRCA2 patients. Further research is required to decipher the association of lower urinary tract symptoms or benign prostate hyperplasia with BRCA carriers.
引用
- Goldberg H, Grievink LS, Mano R, et al. Lower Urinary Tract Symptoms and Benign Prostate Hyperplasia Features Among Male BRCA Mutation Carriers. Urology. 2017. PMID: 28577930. doi:10.1016/j.urology.2017.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。